Affirmable (GB) Horse report

13yo Mare 2007by Doyen (IRE) out of Bella Bellisimo (IRE), by Alzao (USA)

Trainer: Hills J W, Maximum rating: 65, Latest rating: 65

Race record

Form summary
6th HCP on Brighton @ 13 Sep 20106th HCP on Brighton @ 1 Sep 20103rd HCP on Bath @ 5 Aug 20104th HCP on Bath @ 15 Jul 20104th HCP on Brighton @ 29 Jun 20104th MDN on Folkestone @ 7 Jun 20107th MDN on Windsor @ 17 May 20106th MDN on Newmarket @ 14 Aug 2009
6-7444366
Record
Title starts wins seconds thirds earnings
European flat
European flat 8 - - 1 £751
European stakes
European stakes - - - - -
Winning Distances
-
Average winning prize money
-

Race Form

Date Course Dist Type Age Conds Prize Finishing Position Odds Earnings
Date 13 Sep 10 Course Brighton More details Dist 10f Type HCP Age 3 Conds CFG Prize Fin Pos 6th of 12 behind Finch Flyer (IRE) Odds 10/1 Earnings
Date 1 Sep 10 Course Brighton More details Dist 11.9f Type HCP Age 3 Conds CFG Prize Fin Pos 6th of 10 behind Al Shababiya (IRE) Odds 16/1 Earnings
Date 5 Aug 10 Course Bath More details Dist 11.7f Type HCP Age 3 Conds CFG Prize Fin Pos 3rd of 4 behind Raktiman (IRE) Odds 4/1 Earnings £308
Date 15 Jul 10 Course Bath More details Dist 10.2f Type HCP Age 3+ Conds F Prize Fin Pos 4th of 4 behind Fastback (IRE) Odds 7/1 Earnings £241
Date 29 Jun 10 Course Brighton More details Dist 11.9f Type HCP Age 3+ Conds CFG Prize Fin Pos 4th of 7 behind Goldtrek (USA) Odds 13/2 Earnings £202
Date 7 Jun 10 Course Folkestone More details Dist 9.7f Type MDN Age 3+4 Conds CFG Prize Fin Pos 4th of 10 behind Mecox Bay (IRE) Odds 4/1 Earnings
Date 17 May 10 Course Windsor More details Dist 8.3f Type MDN Age 3+ Conds F Prize Fin Pos 7th of 14 behind Heavenly Dawn (GB) Odds 40/1 Earnings
Date 14 Aug 09 Course Newmarket More details Dist 7f Type MDN Age 2 Conds CFG Prize Fin Pos 6th of 16 behind Destination Aim Odds 100/1 Earnings
Show More

Pedigree Extended Pedigree Report

First dam: Bella Bellisimo (IRE) by Alzao (USA)
12 starts
5 starts, 1 win over 9.9f, £2,511
7 starts
8 starts
Unraced in Europe to date.